Globus Medical, Inc.
GMED
Pozycja w akcjach
#2024
Globus Medical, Inc. is a global medical technology company dedicated to... Globus Medical, Inc. is a global medical technology company dedicated to inventing, developing, and marketing a diverse range of healthcare solutions. Their primary focus is on addressing musculoskeletal disorders for patients worldwide. Their extensive portfolio includes a variety of spinal products. These encompass traditional fusion implants like pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices, all designed to treat conditions such as degenerative diseases, deformities, tumors, and trauma. Furthermore, they offer advanced motion preservation technologies, including dynamic stabilization, total disc replacement, and interspinous distraction devices. The company also provides interventional pain management options for vertebral compression fractures, alongside a selection of regenerative biologic products such as allografts and synthetic alternatives. Beyond spinal care, Globus Medical manufactures solutions for orthopedic trauma, featuring products like fracture plates, compression screws, intramedullary nails, and external fixation systems. They also specialize in hip and knee joint reconstruction, offering modular hip stems, acetabular cups, and various knee arthroplasty implants, including posterior stabilizing and cruciate retaining designs. Additionally, the company engages in the distribution of human cell, tissue, and other cellular and tissue-based products. Established in 2003, Globus Medical, Inc. maintains its corporate headquarters in Audubon, Pennsylvania.
Cena akcji
$76.28
Kapitalizacja rynkowa
$10.24B
Zmiana (1 dzień)
-0.45%
Zmiana (1 rok)
28.03%
Kraj
US
Handel Globus Medical, Inc. (GMED)
Kategoria
Healthcare
Marża operacyjna dla Globus Medical, Inc. (GMED)
Marża operacyjna na dzień October 2026 TTM: 20.75%
Według najnowszych raportów finansowych i ceny akcji Globus Medical, Inc., bieżąca marża operacyjna (TTM) wynosi 20.75%. Na koniec 2023 wynosiła 8.49%.
Historia marży operacyjnej dla Globus Medical, Inc. od 2009 do 2026
Marża operacyjna na koniec każdego roku
| Rok | Marża operacyjna | Zmień |
|---|---|---|
| 2026 (TTM) | 20.75% | 214.87% |
| 2024 | 6.59% | -22.38% |
| 2023 | 8.49% | -61.91% |
| 2022 | 22.29% | 24.18% |
| 2021 | 17.95% | 27.12% |
| 2020 | 14.12% | -35.53% |
| 2019 | 21.90% | -7.79% |
| 2018 | 23.75% | -6.68% |
| 2017 | 25.45% | -6.88% |
| 2016 | 27.33% | -13.54% |
| 2015 | 31.61% | 8.36% |
| 2014 | 29.17% | 24.66% |
| 2013 | 23.40% | -21.32% |
| 2012 | 29.74% | 1.26% |
| 2011 | 29.37% | -3.48% |
| 2010 | 30.43% | -5.50% |
| 2009 | 32.20% | 0.00% |
Marża operacyjna dla podobnych firm lub konkurentów
| Firma | Marża operacyjna | Różnica w marży operacyjnej | Kraj |
|---|---|---|---|
| 17.03% | -99.18% |
US
|
|
| 17.86% | -99.14% |
IE
|
|
| 22.03% | -98.94% |
US
|
|
| 21.46% | -98.97% |
US
|
|
| 0.00% | - |
DE
|
Czym jest marża operacyjna firmy?
Marża operacyjna to kluczowy wskaźnik do oceny rentowności firmy. Wyższe marże operacyjne są zazwyczaj korzystniejsze, ponieważ pokazują, że firma może sprzedawać swoje produkty lub usługi znacznie drożej niż koszty ich produkcji. Oblicza się ją, dzieląc zysk firmy przez jej przychody.